Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
HR-011408 by Jiangsu Hengrui Medicine for Type 1 Diabetes (Juvenile Diabetes): Likelihood of Approval
HR-011408 is under clinical development by Jiangsu Hengrui Medicine and currently in Phase I for Type 1 Diabetes (Juvenile Diabetes)....